Evidence map›Paper›PMID 28599458›Full record

ArticleOncology letters2017

Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis.

Zhiwei Zhao, Shichao Wang, Yingbo Lin, Yali Miao, Ye Zeng, Yongmei Nie, Peng Guo, Guangyao Jiang, Jiang Wu

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Diagnostics (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Identification of the interleukin-8 (CXCL-8) pathway in feline oral squamous cell carcinoma - A pilot study.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Zhiwei ZhaoWest China Medical Center, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Shichao WangWest China Medical Center, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Yingbo LinDepartment of Oncology and Pathology, Karolinska Institute, Cancer Centre Karolinska, SE-171 76 Stockholm, Sweden.
Yali MiaoWest China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Ye ZengWest China Medical Center, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Yongmei NieSchool of Basic Medicine, Xinjiang Medical University, Urumqi, Xinjiang 830011, P.R. China.
Peng GuoWest China Medical Center, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Guangyao JiangOutpatient Building, West China Fourth Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Jiang WuWest China Medical Center, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
West China Medical Center of Sichuan University · CNKarolinska Institutet · SESichuan University · CNWest China Second University Hospital of Sichuan University · CNXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epithelial-mesenchymal transition (EMT) is a biological process that is associated with cancer metastasis and invasion. In cancer, EMT promotes cell motility, invasion and distant metastasis. Interleukin (IL)-8 is highly expressed in tumors and may induce EMT. The IL-8/IL-8R axis has a vital role in EMT in carcinoma, which is regulated by several signaling pathways, including the transforming growth factor β-spleen associated tyrosine kinase/Src-AKT/extracellular signal-regulated kinase, p38/Jun N-terminal kinase-activating transcription factor-2, phosphoinositide 3-kinase/AKT, nuclear factor-κB and Wnt signaling pathways. Blocking the IL-8/IL-8R signaling pathway may be a novel strategy to reduce metastasis and improve patient survival rates. This review will cover IL-8-IL-8R signaling pathway in tumor epithelial-mesenchymal transition.

Indexed as

C-X-C motif chemokine receptor 1C-X-C motif chemokine receptor 2epithelial-mesenchymal transitioninterleukin-8metastasisprognosis

Identifiers

PMID28599458
PMCPMC5453110
OpenAlexW2606870926

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.